- Home
- PTGX vs IDA Comparison
PTGX vs IDA Comparison
Compare PTGX & IDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PTGX | IDA |
|---|---|---|
| Founded | 2006 | 1915 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 8.4B |
| IPO Year | 2016 | 1998 |
Fundamental Metrics
Financial Performance| Metric | PTGX | IDA |
|---|---|---|
| Price | $139.40 | $132.13 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 9 |
| Target Price | ★ $174.69 | $157.33 |
| AVG Volume (30 Days) | ★ 535.2K | 461.4K |
| Earning Date | 11-05-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 2.69% |
| EPS Growth | N/A | ★ 7.27 |
| EPS | 2.35 | ★ 5.90 |
| Revenue | N/A | ★ $1,746,972,000.00 |
| Revenue This Year | $1,078.44 | $9.30 |
| Revenue Next Year | N/A | $10.83 |
| P/E Ratio | $60.03 | ★ $22.41 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $62.24 | $124.12 |
| 52 Week High | $160.81 | $154.91 |
Technical Indicators
Market Signals| Indicator | PTGX | IDA |
|---|---|---|
| Relative Strength Index (RSI) | 44.31 | 37.69 |
| Support Level | $132.37 | $124.78 |
| Resistance Level | $142.20 | $144.64 |
| Average True Range (ATR) | 4.59 | 2.05 |
| MACD | -0.44 | 0.15 |
| Stochastic Oscillator | 39.61 | 34.86 |
Price Performance
Historical ComparisonAbout PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.
About IDA IDACORP Inc.
Idacorp is a holding company for Idaho Power. Idacorp is a vertically integrated utility that generates, transmits, and distributes electricity to 670,000 customers in southern Idaho and eastern Oregon. The utility owns 1.8 gigawatts of hydro generation, 400 MW of coal generation, 1.4 GW of natural gas generation, and 300 MW of energy storage.